Table 1. Patient characteristics, N=100 patients for planned segmentectomy.
| Variable | Patients who had a robotic segmentectomy |
|---|---|
| Age years, median | 71 |
| Gender | |
| Male | 50 |
| Female | 50 |
| Ethnicity (n) | |
| White | 88 |
| Black | 11 |
| Other | 1 |
| BMI, median (range) | 27.2 (16.6–38.9) |
| Type of segmentectomy | |
| LUL | 46 (1 converted to lobectomy) |
| Lingulectomy | 6 |
| Anterior segment | 4 |
| Apical segment | 7 |
| Posterior segment | 28 |
| LLL | 15 (1 converted to lobectomy) |
| Superior segment | 14 |
| RUL | 19 (1 converted to lobectomy) |
| Posterior segment | 16 |
| Apical | 2 |
| RLL | 20 (4 converted to lobectomy) |
| Superior segment | 13 |
| Basilar segment | 2 |
| Posterior segment | 1 |
| Final pathology for—patients with lung cancer (N=79) | |
| T1aN0M0 | 56 |
| T1bN0M0 | 14 |
| T2aN0M0 | 9 |
| Histology of primary lung cancer | |
| Adenocarcinoma/lepidic pattern | 5 |
| Adenocarcinoma | 34 |
| Adenocarcinoma + small cell carcinoma | 1 |
| Small cell carcinoma | 1 |
| Squamous cell carcinoma | 29 |
| Large cell neuroendocrine tumor | 9 |
| Lung metastasis cell types | 10 |
| Breast | 1 |
| Melanoma | 1 |
| Prostate | 1 |
| Pancreas | 2 |
| Endometrioid | 1 |
| Colon | 4 |
| Smoking history | Yes (87%) |
| Forced expiratory volume in 1 s, median [range] (%) | 74.5 [28–150] |
| Diffusing capacity of lung for carbon monoxide, median [range] (%) | 67 [25–138] |
| Neoadjuvant therapy | |
| Preoperative chemotherapy | 1 |
| Preoperative radiation | 1 |
| ENB tattooing | 16 |
| Comorbidities (yes %) | |
| Hypertension | 65 |
| Diabetes mellitus | 11 |
| Congestive heart failure | 4.5 |
| CAD, stent | 29 |
| Pulmonary hypertension | 2 |
| Hyperlipidemia | 41 |
| COPD | 37 |
BMI, body mass index; LUL, left upper lobe; LLL, left lower lobe; RUL, right upper lobe; RLL, right lower lobe; ENB, electromagnetic navigational bronchoscopy; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease.